reports
DKSH Holding AG: 1 director
A director at DKSH Holding AG sold 2,000 shares at 58.323CHF and the significance rating of the trade was 59/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly ...
- Carole Braudeau
- Carole Braudeau
Abivax Announces Annual General Meeting Details as Company Advances To...
Abivax Announces Annual General Meeting Details as Company Advances Toward Key 2025 Value-Driving Milestones Abivax Announces Annual General Meeting Details as Company Advances Toward Key 2025 Value-Driving Milestones Annual General Meeting scheduled for Friday, June 6, 2025, in Paris, FrancePhase 3 ABTECT induction trials remain on track: enrollment completion expected in Q2 2025, with top-line induction results expected in Q3 2025 PARIS, France – April 22, 2025 – 10:05 PM CEST – Abivax SA (Euronext Paris: FR0012333284 – ABVX / Nasdaq: ABVX) (“Abivax” or the “Company”), a clinical-stage ...
Abivax Announces Appointment of Dominik Höchli, MD to Board of Directo...
Abivax Announces Appointment of Dominik Höchli, MD to Board of Directors Abivax Announces Appointment of Dominik Höchli, MD to Board of Directors Industry veteran brings deep immunology expertise ahead of key Phase 3 data readout in ulcerative colitis expected in Q3 2025 PARIS, France, April 22, 2025, 10:00 pm CEST – Abivax SA (Euronext Paris: FR0012333284 – ABVX / Nasdaq: ABVX) (“Abivax” or the “Company”), a clinical-stage biotechnology company focused on developing therapeutics that harness the body’s natural regulatory mechanisms to stabilize the immune response in patients with chr...
- Carole Braudeau
- Carole Braudeau
- Carole Braudeau
AXA AXA
CON CONTINENTAL AKTIENGESELLSCHAFT
FME FRESENIUS MEDICAL CARE AG
FNAC FNAC DARTY SA
GRF GRIFOLS S.A. CLASS A
UCG UNICREDIT S.P.A.
ONTEX ONTEX GROUP N.V.
REC RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA S.P.A.
CLNX CELLNEX TELECOM S.A.
ERF EUROFINS SCIENTIFIC SOCIETE EUROPEENNE
SYAB SYNLAB AG
SPM SAIPEM S.P.A.
- Carole Braudeau
AXA AXA
CON CONTINENTAL AKTIENGESELLSCHAFT
FME FRESENIUS MEDICAL CARE AG
FNAC FNAC DARTY SA
GRF GRIFOLS S.A. CLASS A
UCG UNICREDIT S.P.A.
ONTEX ONTEX GROUP N.V.
REC RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA S.P.A.
CLNX CELLNEX TELECOM S.A.
ERF EUROFINS SCIENTIFIC SOCIETE EUROPEENNE
SYAB SYNLAB AG
SPM SAIPEM S.P.A.
Intesa Sanpaolo S.p.A.: 1 director
A director at Intesa Sanpaolo S.p.A. sold 5,462 shares at 4.733EUR and the significance rating of the trade was 52/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cl...
- Carole Braudeau
Credit Morning 03/31/2025
Moody’s places Fives CFR on CW positive|Acqua e Sapone: preliminary full-year earnings|Fnac Darty launches the repurchase invitation for 2027 OCEANES at a price of € 77.25|Maxeda bondholders start to organize (9fin)|Telecom Italia: Poste Italiane replaces Vivendi as the largest shareholder|
- Carole Braudeau
Morning Crédit 31/03/2025
Moody’s places Fives CFR on CW positive|Acqua e Sapone : résultats annuels préliminaires|Fnac Darty annonce le lancement de l’offre de rachat des OCEANES 2027 au prix de 77,25 EUR|Maxeda : Les principaux créanciers auraient commencé à s’organiser|Telecom Italia : Poste Italiane remplace Vivendi en tant que principal actionnaire|
- Andreas Riemann
- Jean Danjou
- Marc Lavaud
- Youssef Besbes
ZIL2 ELRINGKLINGER AG
A1XEH4 CROSSJECT SA
TNG TRANSGENE SA
CGM CEGEDIM SA
BOSS HUGO BOSS AG
NANO NANOBIOTIX SA
SESL SES-IMAGOTAG SA
XIL XILAM ANIMATION SA
ALR ALIOR BANK SA
JUN3 JUNGHEINRICH AG PREF
DMP DERMAPHARM HOLDING SE
TGN SOCIETATEA NATIONALA DE TRANSPORT GAZE NATURALE TRANSGAZ S.A.
VOS VOSSLOH AG
2CRSI 2CRSI SA
GRE GRENERGY RENOVABLES
CLA CLARANOVA SE
SFQ SAF-HOLLAND SE
MRX MISTER SPEX SE
ENER GRUPO ECOENER S.A.
LOUP SOCIETE L.D.C.
- Andreas Riemann
- Jean Danjou
- Marc Lavaud
- Youssef Besbes
ZIL2 ELRINGKLINGER AG
A1XEH4 CROSSJECT SA
TNG TRANSGENE SA
HCO HIGHCO SA
CGM CEGEDIM SA
BOSS HUGO BOSS AG
NANO NANOBIOTIX SA
SESL SES-IMAGOTAG SA
XIL XILAM ANIMATION SA
ALR ALIOR BANK SA
JUN3 JUNGHEINRICH AG PREF
DMP DERMAPHARM HOLDING SE
TGN SOCIETATEA NATIONALA DE TRANSPORT GAZE NATURALE TRANSGAZ S.A.
VOS VOSSLOH AG
2CRSI 2CRSI SA
GRE GRENERGY RENOVABLES
CLA CLARANOVA SE
SFQ SAF-HOLLAND SE
MRX MISTER SPEX SE
ENER GRUPO ECOENER S.A.
LOUP SOCIETE L.D.C.
- Andreas Riemann
DKSH’s 92nd Annual General Meeting 2025
DKSH Management Ltd. / Key word(s): AGMEGM/Dividend DKSH’s 92nd Annual General Meeting 2025 27.03.2025 / 17:45 CET/CEST Media releaseShareholders approved all motions with a clear majority Reelection of the current Board members seeking another term as well as the Chairman of the Board of Directors, and appointment of a new Board member Proposal of dividend increase of 4.4% to CHF 2.35 per share accepted Zurich, Switzerland, March 27, 2025 – DKSH has held its 92nd Annual General Meeting where shareholders have voted in favor of all motions by a clear majority. In total, 166 share...
EQS-News: Abivax publishes financial reports with the French and U.S....
EQS-News: ABIVAX / Key word(s): Annual Report Abivax publishes financial reports with the French and U.S. securities regulatory agencies 26.03.2025 / 22:05 CET/CEST The issuer is solely responsible for the content of this announcement. Abivax publishes financial reports with the French and U.S. securities regulatory agencies PARIS, France – March 26, 2025 – 10:05 PM CET – Abivax SA (Euronext Paris & Nasdaq: ABVX) (“Abivax” or the “Company”), a clinical-stage biotechnology company focused on developing therapeutics that harness the body’s natural regulatory mechanisms t...
Abivax publishes financial reports with the French and U.S. securities...
Abivax publishes financial reports with the French and U.S. securities regulatory agencies Abivax publishes financial reports with the French and U.S. securities regulatory agencies PARIS, France – March 26, 2025 – 10:05 PM CET – Abivax SA (Euronext Paris & Nasdaq: ABVX) (“Abivax” or the “Company”), a clinical-stage biotechnology company focused on developing therapeutics that harness the body’s natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases, announces the filing of its Universal Registration Document (Document d’Enregistrement...
DKSH Technology Strengthens its Korean Business with the Acquisition o...
DKSH Management Ltd. / Key word(s): Takeover DKSH Technology Strengthens its Korean Business with the Acquisition of MDxK 26.03.2025 / 07:00 CET/CEST Media releaseDKSH has signed an agreement to acquire Molecular Diagnostics Korea Inc. (“MDxK”), a well- established player in the South-Korean life-science space. With this transaction, DKSH Technology further extends its scientific solutions business in line with the Business Unit’s strategy to solidify its position as a leading scientific solutions provider in Asia and Beyond. Zurich, Switzerland, March 26, 2025 – DKSH has announced...
- Stephane Beyazian
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.